ClinicalTrials.Veeva

Menu

Effect of Intake of Dehydrated Nopal Powder From Highly Mature Cladodes on the Lipid Profile

U

Universidad Autónoma de Querétaro

Status

Completed

Conditions

Overweight
Obesity
Dyslipidemia

Treatments

Other: Control Group (only diet)
Dietary Supplement: supplementation with 5 g dehydrated nopal powder from highly mature cladodes
Dietary Supplement: supplementation with 15 g dehydrated nopal powder from highly mature cladodes

Study type

Interventional

Funder types

Other

Identifiers

NCT07018908
FCN-10310

Details and patient eligibility

About

Background: Opuntia ficus-indica is a plant from the cactus family (Cactaceae) that is widespread and of great economic importance in Mexico. It has been consumed as food since pre-Hispanic times and is currently considered a nutraceutical. In this study, the effect of consumption of dehydrated nopal powder from highly mature cladodes (Opuntia ficus-indica) on the lipid profile of overweight or obese patients diagnosed with dyslipidemia was investigated. Methods: A 3-month prospective clinical trial was conducted in 35 overweight or obese patients with dyslipidemia. The sample was divided into three groups with a daily intake of 30 g of dietary fiber: Group I received 5 g of dehydrated Opuntia ficus-indica cladodes plus the standard normocaloric diet for dyslipidemia, Group II received 15 g plus the diet, and Group III followed only the diet.

Enrollment

35 patients

Sex

All

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants with dyslipidemia, confirmed by lipid meas-urement in blood chemistry
  • overweight or obesity
  • A cardiovascular risk factor associated with abdominal obesity

Exclusion criteria

  • Patients with a suspected diagnosis of primary dyslipidemia
  • Diabetes
  • Hypertension
  • Thyroid disease were excluded from the study
  • Patients with complex or severe disease such as heart failure, liver or kidney disease
  • Pregnant or lactating women
  • Indidividuals taking lipid-modifying drugs or hormone replacement therapy - Patients with gastrointestinal problems and deficiencies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

35 participants in 3 patient groups

Group I (first arm): 5 g of dehydrated nopal + normocaloric diet.
Active Comparator group
Description:
Supplementation: 5 g of dehydrated nopal (2.47 g of fiber per day), reconstituted in water, taken before breakfast. Diet: 27.53 g of fiber per day, Normocaloric diet: Carbohydrates: 55%, Lipids 25% and Proteins 20%
Treatment:
Dietary Supplement: supplementation with 5 g dehydrated nopal powder from highly mature cladodes
Group II (second arm): 15 g of dehydrated nopal + normocaloric diet.
Active Comparator group
Description:
Supplementation: 15 g of dehydrated nopal (7.42 g of fiber per day), reconstituted in water, taken before breakfast and at night. Diet: 22.58 g of fiber per day, Normocaloric diet: Carbohydrates 55%, Lipids 25% and Proteins 20%
Treatment:
Dietary Supplement: supplementation with 15 g dehydrated nopal powder from highly mature cladodes
Group III (third arm): normocaloric diet only (control or comparison group).
Other group
Description:
No dehydrated nopal or placebo. 30 g of fiber per day Normocaloric diet Carbohydrates 55%, Lipids 25% and Proteins 20%
Treatment:
Other: Control Group (only diet)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems